ARAY Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 16:00):
Our systems believe the stock currently is overvalued by -0.73% compare to its pairs and should correct downwards.

Stats
Today's Volume	1.11M
Average Volume	663 512
Market Cap	180.62M
EPS	$-0.0639 ( Q3 \| 2024-05-08 )
Next earnings date	( $0.0400 ) 2024-08-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.27 (Sector) 42.63 (Industry) 0
ATR14	$0.00400 (0.22%)

AEMD -13.81%

AFIB -13.41%

AHCO 1.42%

AHPI 0.00%

ALGN -0.65%

ANIK -1.52%

APEN 0.00%

APYX -4.96%

ARAY 1.68%

ATEC 0.58%

AXDX 1.74%

AXGN 0.28%

AXNX -0.25%

AZYO 2.05%

BBLG 0.83%

BIOL 38.50%

BJDX -6.77%

BMRA -2.16%

BRKR -0.61%

BSGM -5.35%

BWAY 0.83%

CERS 0.57%

CFMS 0.44%

CLPT -5.11%

CODX -1.57%

CSII 0.15%

CTKB 1.64%

CTSO -9.00%

CUTR 3.42%

CVRX 2.48%

DCTH 1.70%

DXCM -1.01%

DYNT -20.97%

EAR -4.10%

ECOR -0.16%

EDAP 4.21%

ESTA 3.56%

FONR 1.46%

HJLI -1.98%

HSDT -1.99%

HSKA 0.00%

HYPR -11.00%

IART 1.36%

ICAD 0.00%

ICCM -1.99%

IINN -2.13%

INGN 2.01%

INMD 1.00%

IRIX 0.00%

IRMD -0.05%

IRTC 3.12%

ISO 0.00%

ITMR 0.00%

KIDS -0.10%

LHDX 0.00%

LIVN -0.02%

LNSR 2.74%

LUCD -5.64%

LUNG 2.76%

MASS 0.00%

MDGS 10.28%

MOTS 0.17%

MOVE -3.51%

MSON 0.00%

NAOV -5.41%

NARI 2.47%

NMRD 0.00%

NNOX 10.71%

NPCE 8.00%

NTUS 0.00%

NURO 0.27%

NUVA -2.24%

NUWE 18.57%

NVCN 0.00%

NVNO 1.55%

OBLN -5.86%

OFIX -1.63%

OM -7.00%

PACB 0.74%

PAVM 6.30%

PETV 0.00%

PODD -2.50%

PRCT 2.28%

PROF -4.88%

QIPT 3.54%

QTRX 1.62%

RCEL -0.38%

RPID -4.90%

RSLS -3.23%

RWLK 6.07%

RXST 1.81%

SGHT 1.99%

SIBN 4.02%

SIEN -18.69%

SILK 0.52%

SINT -6.98%

SOLY 0.00%

SRDX 0.17%

SRGA 0.00%

SRTS 1.72%

SWAV 0.00%

TBIO -8.29%

TCMD 3.20%

TELA -8.56%

THMO 9.52%

TIVC -1.02%

TLIS 0.72%

TMCI 0.15%

TMDI 0.00%

TMDX 1.89%

TNDM -0.35%

TNON 0.00%

UFPT 2.41%

VERO -2.71%

VIVE 0.00%

VMD 1.24%

VRAY 0.00%

VREX 0.75%

VVOS -7.11%

XAIR -7.38%

XENT 0.00%

ZIMV 3.75%

Insider Trading

Date	Person	Action	Amount	type
2023-12-01	Chalke Sandeep	Sell	26 799	Common Stock
2024-06-04	Pervaiz Ali	Sell	2 701	Common Stock
2024-05-29	Whitters Joseph E	Buy	50 000	Common Stock
2024-05-28	Whitters Joseph E	Buy	50 000	Common Stock
2024-03-01	Hoge Michael	Sell	11 991	Common Stock

INSIDER POWER
69.76
Last 97 transactions
Buy: 4 928 361 \| Sell: 673 784

Correlation (AI algo v.1.1b): Overvalued: -0.73% $1.823 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.60 (weak)

Short: 0.58 (weak)

Signal:(62.573) Neutral

Accuray Inc Correlation

10 Most Positive Correlations
OZEM	1
APDN	0.938
HUGE	0.931
WVVI	0.931
ASNS	0.931
LINK	0.929
VAXX	0.928
ALLR	0.922
ISSC	0.92
INTC	0.92

10 Most Negative Correlations
AEYE	-0.948
GGAL	-0.946
JAGX	-0.946
NEXT	-0.944
SGMA	-0.941
IZEA	-0.94
VCTR	-0.932
THCP	-0.932
SMTC	-0.931
PI	-0.93

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Accuray Inc Correlation - Currency/Commodity

-0.14
( neutral )

0.00
( neutral )

-0.15
( neutral )

Accuray Inc Financials

Annual	2023
Revenue:	$447.61M
Gross Profit:	$153.96M (34.40 %)
EPS:	$-0.0978

FY	2023
Revenue:	$447.61M
Gross Profit:	$153.96M (34.40 %)
EPS:	$-0.0978

FY	2022
Revenue:	$429.91M
Gross Profit:	$159.96M (37.21 %)
EPS:	$-0.0581

FY	2021
Revenue:	$396.29M
Gross Profit:	$159.51M (40.25 %)
EPS:	$-0.0700

Financial Reports:

No articles found.

Accuray Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.